ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 14.78
-1.82 (-10.96%)
Feb 5, 2026, 5:29 PM CET
STO:EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 2.30M SEK in the quarter ending September 30, 2025, with 36.06% growth. This brings the company's revenue in the last twelve months to 10.85M, up 36.83% year-over-year. In the year 2024, ExpreS2ion Biotech Holding AB had annual revenue of 7.83M, down -11.07%.
Revenue (ttm)
10.85M
Revenue Growth
+36.83%
P/S Ratio
4.81
Revenue / Employee
542.60K
Employees
20
Market Cap
52.18M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.83M | -974.00K | -11.07% |
| Dec 31, 2023 | 8.80M | 2.65M | 43.07% |
| Dec 31, 2022 | 6.15M | -7.58M | -55.21% |
| Dec 31, 2021 | 13.73M | -1.53M | -10.04% |
| Dec 31, 2020 | 15.26M | 1.43M | 10.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alligator Bioscience AB | 46.22M |
| Alzinova AB | 26.12M |
| Nanologica AB | 22.65M |
| AcouSort AB | 10.80M |
| Spago Nanomedical AB | 5.84M |
| OncoZenge AB | 2.78M |
| Simris Group AB (PUBL) | 2.30M |
| 2cureX AB | 1.98M |